Part of Reports Series: Zyne company information

zyne about us

Accuracy score :
97%

 

    

Zyne is a private research company focused on U.S. Shares, china A-Shares and hong kong equities operating out of Queens, New York.

 

  • Value Growth is our investing method
  • Onsite (in china or U.S.) evaluations is how we do our research.
  • 5-8 years is our preferred holding time.
  • 10-k Analysis reports is how we evaluate companies.
  • 200-1000% is our expected return from each investment.

Expertise

  • Risk calculation for events, subject, or forward projection
  • Value calculation for most subjects
  • Buy , Sell or Hold analysis
  • Simple Structural Planning for Growth
  • Create & maintain Alpha (financial)


Our products include Analysis Reports and AutoApp Management Software.

 

 

The Reports that you may like

Stock Title % of value Value per share 2018-11-16
(Zyne) Zyne Pricing -256.67 -3.0000 2018-11-02
(zyne) Zyne Trial and Error -256.67 -3.0000 2018-11-14
(zyne) Zyne Circle of Life -256.67 -3.0000 2018-11-08
(zyne) Zyne Top signs of a weakened Immune System -256.67 -3.0000 2018-11-09
(zyne) Zyne Risk Units as a method to contain Risk -256.67 -3.0000 2018-11-09